Older drugs with limited trial evidence: Are they worth the expense? The case of repository corticotropin marketed as H.P. Acthar Gel

Ali Duarte-García, Eric L. Matteson, Nilay D. Shah

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Older drugs with limited trial evidence: Are they worth the expense? The case of repository corticotropin marketed as H.P. Acthar Gel'. Together they form a unique fingerprint.